Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 3 11Phase 2/3 4Phase 1/2 4Phase 4 3Phase 1 3Phase NA 1

Status

Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER_GOV 1OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 5Stomach Neoplasms 4Advanced Gastric Cancer 3Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Small Cell Lung Carcinoma 1Respiratory Tract Diseases 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lung Diseases 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Liver Neoplasms 1Hepatic Metastasis of Colorectal Cancer 1Head and Neck Neoplasms 1Glioma 1Colorectal Neoplasms 1Colorectal Cancer Recurrent 1Biliary Tract Neoplasms 1Advanced Triple Negative Breast Cancer 1Advanced Solid Tumors 1

Interventions

pembrolizumab 26Paclitaxel 22Oxaliplatin 20Nivolumab 16Docetaxel 16Capecitabine 16Cisplatin 15Fluorouracil 11Cyclophosphamide 11fludarabine 10S 1 (combination) 10Trastuzumab 9Irinotecan 9Carboplatin 8Leucovorin 7tislelizumab 6aldesleukin 5Ramucirumab 5Interleukin-2 5Gemcitabine 5Drug Therapy 5Bevacizumab 5sintilimab 4fludarabine phosphate 4apatinib 4Radiotherapy 4Everolimus 4regorafenib 3olaparib 3durvalumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Stomach Neoplasms × apatinib × Clear all
NCT04581473 2025-06-05

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

CARsgen Therapeutics Co., Ltd.

Phase 1/2 Active not recruiting
192 enrolled
Gastrointestinal

Pancreatic Neoplasms, Stomach Neoplasms

NCT03707028 2022-04-11

A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer

Elevar Therapeutics

Phase 1/2 Terminated
12 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03599778 2018-07-26

XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma

Anhui Provincial Hospital

Phase 1/2 Unknown
52 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02942329 2018-02-26

Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase 1/2 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡